Primary myelofibrosis but not autoimmune myelofibrosis accompanied by Sjögren's syndrome and primary biliary cirrhosis in a patient with trisomy 8 mosaic: a case report and literature review.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Clinical and Experimental Rheumatology

• Publication date

  2018-05-01

• Fields of study

  Medicine

• Identifiers
  PMID 29745886
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Allogeneic stem-cell transplantation for myelofibrosis

  2017cited by this paper
• Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial

  2017cited by this paper
• Sjögren's syndrome: from pathogenesis to novel therapeutic targets.

  2016cited by this paper
• The Coexistence of Sjögren's Syndrome and Primary Biliary Cirrhosis: A Comprehensive Review

  2015cited by this paper
• Fibrogenesis in Primary Myelofibrosis: Diagnostic, Clinical, and Therapeutic Implications.

  2015cited by this paper
• Cutaneous T‐cell lymphoma: 2014 Update on diagnosis, risk‐stratification, and management

  2014cited by this paper
• Autoimmune myelofibrosis: an update on morphologic features in 29 cases and review of the literature.

  2014cited by this paper
• A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis.

  2012cited by this paper
• Preliminary clinical activity of a topical JAK1/2 inhibitor in the treatment of psoriasis.

  2012cited by this paper
• Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond

  2011cited by this paper
• Conventional cytogenetics in myelofibrosis: literature review and discussion

  2009cited by this paper
• Primary myelofibrosis.

  2008cited by this paper
• Primary myelofibrosis in a patient who developed primary biliary cirrhosis, autoimmune hemolytic anemia and fibrillary glomerulonephritis

  2008cited by this paper
• Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms

  2008cited by this paper
• Primary autoimmune myelofibrosis: Definition of a distinct clinicopathologic syndrome

  2003cited by this paper
• Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes

  2000cited by this paper
• An uncommon association: Sjögren's syndrome and autoimmune myelofibrosis.

  1999cited by this paper
• The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.

  1998cited by this paper
• Karyotypic patterns in chronic myeloproliferative disorders: report on 74 cases and review of the literature.

  1991cited by this paper
• FIBROSIS OF THE BONE MARROW: CONTENT AND CAUSES

  1985cited by this paper

• Quantitative assessment of innate myeloid cells in myelofibrosis: insights into myeloid and plasmacytoid dendritic cell depletion and disease progression

  2025cites this paper
• Single-center study on features of immune mediated diseases in JAK2 (V617F)-positive myeloproliferative neoplasms and the potential therapeutic role of JAK inhibitors.

  2023cites this paper
• Autoimmune Complications in Hematologic Neoplasms

  2021cites this paper